Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$736,584
+$18,659 QoQ
Shares Held
4,700
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#733
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. NVS ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
This page
|
4,700 | $736,584 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $736,584 | 4,700 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $717,925 | 4,700 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $647,989 | 4,700 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $602,728 | 4,700 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $568,747 | 4,700 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $523,956 | 4,700 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $457,357 | 4,700 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $540,594 | 4,700 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $500,362 | 4,700 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $454,631 | 4,700 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $464,462 | 4,600 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $488,928 | 4,800 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $484,368 | 4,800 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $423,200 | 4,600 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $534,885 | 5,896 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $357,247 | 4,700 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $380,385 | 4,500 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $394,875 | 4,500 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $408,047 | 4,665 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $487,817 | 5,965 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $529,192 | 5,800 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $505,357 | 5,912 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $558,270 | 5,912 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $514,107 | 5,912 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $516,354 | 5,912 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $456,113 | 5,532 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||